DeniseKSebasigariDO
Neurology • Oklahoma City, OKEpilepsy, Neurophysiology
Assistant Professor of Neurology/ Epilepsy- The University of Oklahoma Health Sciences Center
Dr. Sebasigari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
OU Physicians Building
825 NE 10th Street, Suite 5B
Oklahoma City, OK 73104Phone+1 405-271-3635Fax+1 405-271-5723
Summary
- Dr. Sebasigari is a board certified neurologist specializing in Epilepsy. She completed her residency at Alpert Brown Medical School-Rhodes Island Hopsital in Povidence, RI and completed surgical epilepsy fellowship/neurophysiology fellowship at UT-Houston Medical School, Texas Medical Center ( level 4 epilepsy center). Her areas of interest are women with epilepsy and intractable epilepsy/surgical epilepsy.
Education & Training
Rhode Island Hospital/Brown University HealthResidency, Neurology, 2013 - 2016
Texas College of Osteopathic MedicineClass of 2012
Certifications & Licensure
TX State License 2016 - 2026
OK State License 2019 - 2025
RI State License 2013 - 2016
OH State License 2012 - 2013
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Clinical Neurophysiology
Publications & Presentations
PubMed
- 20 citationsBiomarkers of Atrial Cardiopathy and Atrial Fibrillation Detection on Mobile Outpatient Continuous Telemetry After Embolic Stroke of Undetermined Source.Denise Sebasigari, Alexander E Merkler, Yang Guo, Gino Gialdini, Benjamin R Kummer
Journal of Stroke and Cerebrovascular Diseases. 2017-06-01 - 67 citationsMDM2 antagonist nutlin-3 displays antiproliferative and proapoptotic activity in mantle cell lymphoma.Yoko Tabe, Denise Sebasigari, Linhua Jin, Martina Rudelius, Theresa Davies-Hill
Clinical Cancer Research. 2009-02-01 - 34 citationsExpression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker.Antonio Martinez, Stefania Pittaluga, Martina Rudelius, Theresa Davies-Hill, Denise Sebasigari
The American Journal of Surgical Pathology. 2008-08-01
Press Mentions
What It’s like to Treat Asylum Seekers and Refugees in the US, OverseasOctober 28th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
